Startseite>>Signaling Pathways>> Neuroscience>> Muscarinic Receptor>>AF-DX 384

AF-DX 384

Katalog-Nr.GC15510

AF-DX 384 ist ein selektiver Antagonist der muskarinischen Acetylcholinrezeptoren M2 und M4 (Kis = 6,03 bzw. 10 nM).

Products are for research use only. Not for human use. We do not sell to patients.

AF-DX 384 Chemische Struktur

Cas No.: 118290-26-9

Größe Preis Lagerbestand Menge
1mg
46,00 $
Auf Lager
5mg
125,00 $
Auf Lager
10mg
209,00 $
Auf Lager
50mg
879,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties of AF-DX 384

Cas No. 118290-26-9 SDF
Chemical Name (Z)-N-(2-(2-((dipropylamino)methyl)piperidin-1-yl)ethyl)-6-hydroxy-11H-benzo[e]pyrido[3,2-b][1,4]diazepine-11-carbimidic acid
Canonical SMILES CCCN(CC1CCCCN1CC/N=C(O)/N2C3=CC=CC=C3C(O)=NC4=C2N=CC=C4)CCC
Formula C27H38N6O2 M.Wt 478.64
Löslichkeit DMSO: 50 mM; Ethanol: 10 mM Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of AF-DX 384

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.0893 mL 10.4463 mL 20.8925 mL
5 mM 0.4179 mL 2.0893 mL 4.1785 mL
10 mM 0.2089 mL 1.0446 mL 2.0893 mL
  • Molaritätsrechner

  • Verdünnung-Rechner

  • Molecular Weight Calculator

Gewicht
=
Konzentration
x
Inhalt
x
MW*
 
 
 
**Bei der Herstellung von Stammlösungen ist immer das chargenspezifische Molekulargewicht von

Berechnen

In vivo Formulation Calculator (Clear solution) of AF-DX 384

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Bewertungen

Review for AF-DX 384

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AF-DX 384

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.